Aegerion Pharmaceuticals, Inc.
(NASDAQ : AEGR)

( )
AEGR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
LLYEli Lilly and Company
1.26%129.911.0%$4447.54m
PFEPfizer Inc.
0.12%41.900.9%$1047.05m
BMYBristol-Myers Squibb Company
-1.37%47.501.4%$976.57m
JNJJohnson & Johnson
-0.21%136.620.7%$890.09m
MRKMerck & Co., Inc.
0.11%82.380.6%$779.73m
ABBVAbbVie, Inc.
-0.30%79.522.2%$476.55m
AZNAstraZeneca PLC Sponsored ADR
-0.09%42.551.3%$179.78m
NVSNovartis AG Sponsored ADR
-0.12%93.310.2%$178.68m
GSKGlaxoSmithKline plc Sponsored ADR
-0.10%41.210.2%$86.65m
NVONovo Nordisk A/S Sponsored ADR Class B
1.66%51.560.1%$59.50m
SNYSanofi Sponsored ADR
-0.70%43.950.2%$54.36m
AKTXAkari Therapeutics Plc Sponsored ADR
-10.00%3.691.6%$20.70m
LCILannett Company, Inc.
0.42%7.1936.7%$9.55m
EPIXESSA Pharma Inc
2.32%3.530.1%$0.03m

Company Profile

Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer and William H. Lewis on January 5, 2011 and is headquartered in Cambridge, MA.